Your session is about to expire
← Back to Search
Sleep Schedule Restriction for Alzheimer's Disease (ALPS Trial)
ALPS Trial Summary
This trial will explore whether better sleep can help mitigate the effects of Alzheimer's disease.
ALPS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowALPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ALPS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a score higher than 10 on the Epworth sleepiness test.You drink more than 14 alcoholic drinks per week or more than 6 drinks at one time.You have a serious mental health condition like severe depression, panic disorder, substance abuse, or bipolar disorder.I take medication to help me sleep at night.You have a high sleep efficiency and wake up for less than 20 minutes during the night.You work at night or regularly between 12am and 6am.You are afraid of being in small or enclosed spaces.My BMI is over 40, indicating severe obesity.You can see and hear normally or with corrective lenses or aids.I have a long-term health issue that greatly impacts my sleep.You stop breathing or have shallow breathing more than 15 times in one night, as measured by a special test called Apnea Link Plus.You have trouble sleeping, as shown by your sleep diary and activity tracker, with a low sleep efficiency and long periods of being awake after falling asleep.I had a car accident or a close call because of falling asleep in the last year.You scored below 23 on a test that checks how well you can think and remember things over the phone.You drink more than 3 caffeinated drinks each day.I have a history of serious brain or nervous system conditions.I am currently taking medication that affects my sleep.You have metal inside your body.I am between 65 and 85 years old.
- Group 1: Control
- Group 2: Time in Bed Restriction
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research study accept participants who are younger than 25 years old?
"According to the trial's inclusion criteria, elderly adults between 65 and 85 years of age are eligible for enrollment."
What is the maximum capacity for enrollees in this experiment?
"Affirmative. The particulars of the trial are accessible on clinicaltrials.gov, which confirms that it is presently seeking candidates to participate in this experiment; with its initial post date being 3rd January 2022 and last update occurring 25th October 2022. 116 participants must be sourced from a singular research facility."
What are the eligibility criteria for participating in this research trial?
"This trial is recruiting 116 individuals with amyloidosis between 65 and 85 years of age. Eligibility for the study requires that participants have normal or corrected vision/hearing, a mean sleep efficiency below 90% as estimated by diary and actigraphy recordings, and wake time after initial falling asleep exceeding 20 minutes based on journal entries and activity tracking data."
What aims is this investigation trying to reach?
"The primary purpose of this research is to assess overnight memory retention on the AB paired associate task and preclinical Alzheimer's cognitive composite score over baseline and 4 weeks. Secondary objectives include measuring changes in response time, accuracy, and sleep efficiency associated with executive function tasks as well as proportion of time spent sleeping while in bed."
Are there open slots for the current clinical trial?
"Affirmative. According to the clinicaltrials.gov website, this investigation is actively seeking volunteers with a launch date of March 1st 2022 and an update on October 25th 2022. A total of 116 individuals must be recruited from one medical centre in order for the study to progress as planned."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger